Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015)

R Ofori-Asenso, P Brhlikova, AM Pollock - BMC public health, 2016 - Springer
Background Rational medicine use is essential to optimize quality of healthcare delivery and
resource utilization. We aim to conduct a systematic review of changes in prescribing …

What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs

SS Dunne, CP Dunne - BMC medicine, 2015 - Springer
Background Considerable emphasis is presently being placed on usage of generic
medicines by governments focussed on the potential economic benefits associated with …

Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines

S Dumbreck, A Flynn, M Nairn, M Wilson, S Treweek… - bmj, 2015 - bmj.com
Objective To identify the number of drug-disease and drug-drug interactions for exemplar
index conditions within National Institute of Health and Care Excellence (NICE) clinical …

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic …

S Dunne, B Shannon, C Dunne, W Cullen - BMC Pharmacology and …, 2013 - Springer
Generic medicines are those where patent protection has expired, and which may be
produced by manufacturers other than the innovator company. Use of generic medicines …

Comparing generic drug markets in Europe and the United States: prices, volumes, and spending

OJ Wouters, PG Kanavos, M McKee - The Milbank Quarterly, 2017 - Wiley Online Library
Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration

BM Davit, PE Nwakama, GJ Buehler… - Annals of …, 2009 - journals.sagepub.com
Background: In the US, manufacturers seeking approval to market a generic drug product
must submit data demonstrating that the generic formulation provides the same rate and …

Pharmakologie und Toxikologie

M Freissmuth, S Offermanns, S Böhm - 2016 - Springer
Das Schreiben eines neuen Lehrbuchs ist nicht nur eine Herausforderung, sondern auch
ein Risiko. Denn es lässt sich nicht leicht vorhersehen, wie gut das Lehrbuchkonzept bei …

Physician perceptions about generic drugs

WH Shrank, JN Liberman, MA Fischer… - Annals of …, 2011 - journals.sagepub.com
Background With constrained health-care resources, there is a need to understand barriers
to cost-effective medication use. Objective To study physician perceptions about generic …

Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study

JJ Gagne, NK Choudhry, AS Kesselheim… - Annals of internal …, 2014 - acpjournals.org
Background: Statins are effective in preventing cardiovascular events, but patients do not
fully adhere to them. Objective: To determine whether patients are more adherent to generic …

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis

AS Kesselheim, MR Stedman, EJ Bubrick, JJ Gagne… - Drugs, 2010 - Springer
Background: The automatic substitution of bioequivalent generics for brand-name
antiepileptic drugs (AEDs) has been linked by anecdotal reports to loss of seizure control …